Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Pediatric Neurology

The Symptoms of PIGT-related MCAHS3

At a Glance

PIGT-related MCAHS3 can cause early seizures, low muscle tone, developmental delay, and variable brain, eye, bone, kidney, heart, or hearing findings. Symptoms differ widely, so each child's care plan is individualized.

PIGT-related MCAHS3 (also known as PIGT-CDG) is a “multi-system” disorder because the missing molecular tethers it causes are needed by proteins all over the body. While the condition follows a general pattern, it is important to know that symptoms can vary widely—even between siblings with the same genetic change [1][2]. Keep in mind that not every reported feature requires routine screening; your team will guide you.

Neurological Symptoms

The brain and nervous system are commonly affected because they rely heavily on tethered proteins for stable electrical activity and growth [3].

  • Hypotonia (Low Muscle Tone): This is often one of the first signs parents notice. A baby may feel “floppy” in your arms and have difficulty holding up their head or reaching motor milestones like sitting or crawling [3][4].
  • Seizures (Epilepsy): Seizures are a hallmark of this condition and typically begin early—often in infancy, though onset is variable [3][1]. The types of seizures can vary and may include:
    • Focal or Generalized Seizures [1].
    • Tonic Seizures [5].
    • Ictal Apnea: Seizure-associated breathing pauses reported in some patients [5]. Any unexplained breathing pause is an emergency.
    • Myoclonic-Atonic Seizures [1].
  • Developmental Delay: Most children have significant challenges with learning and movement (global developmental delay) [3]. Some children may eventually learn to walk or use words, while others may remain non-verbal and require full support for all daily needs [1][6].
  • Brain Structure: In some children, brain scans (MRI) show that the brain is smaller than expected (atrophy) or that the protective coating on nerves (myelin) is slow to develop [5][4].

Eye (Ophthalmic) Symptoms

The “O” in the long descriptive name for this syndrome refers to “ophthalmic” or eye issues. Because the proteins needed for vision also require tethers, the eyes may not develop or function correctly [7].

  • Vision Impairment: Some children are reported to have reduced vision, which can be caused by the brain’s processing of images or issues within the eye itself [7].
  • Structural Issues: Doctors have reported rare cases of anterior segment dysgenesis (abnormal development of the front of the eye) and retinal detachment (where the light-sensing part of the eye pulls away) [7].
  • Eye Movement: Some children have strabismus (eyes that don’t line up, such as “crossed eyes”) or nystagmus (involuntary “dancing” eye movements) [8][2].

Bone and Skeletal Symptoms

Skeletal symptoms are reported in some individuals but are inconsistent; some children have bone issues, while others have none at all [4][9].

  • Bone Density and Growth: Because the enzyme needed to harden bones (ALP) is often missing its tether, some babies have been reported with fractures or delayed bone age (bones that look “younger” on X-rays than the child’s actual age) [10][7].
  • Joint and Limb Differences: Reported features include joint hypermobility (very flexible joints) and talipes equinovarus (clubfoot) [2][8].
  • Hand and Foot Differences: Some children have minor differences in their fingers or toes, often called digital anomalies [2].

Other Potential Symptoms

Because the PIGT gene is active throughout the body, other organs can sometimes be involved:

  • Kidneys: Some rare individual reports note renal cysts (small fluid-filled sacs) or issues with how urine flows [8][2].
  • Heart: Minor heart structure differences, such as the heart being positioned slightly differently in the chest (dextroposition), have been noted rarely [8].
  • Hearing: A few individual cases of children with hearing loss have been reported [2].

A Spectrum of Severity

It is natural to look for a predictable “path,” but the severity of these symptoms is highly variable. Some specific genetic changes (variants) have been reported in a small number of individuals to associate with a “milder” path where seizures are easier to control with medication and developmental delays are less profound [1]. Others face a much steeper climb with “pharmacoresistant” seizures that are difficult to stop [3][1]. Your child’s care team will help you understand where on this spectrum your child’s specific symptoms may fall.

Common questions in this guide

What are the main symptoms of PIGT-related MCAHS3?
The most prominent features are low muscle tone, early-onset seizures, and global developmental delay. Some children also have brain imaging changes, vision or eye-movement problems, skeletal differences, or less common kidney, heart, or hearing findings. Severity varies widely.
When do seizures begin in children with PIGT-related MCAHS3, and what types can occur?
Seizures often begin in infancy, although the age of onset can vary. Reported types include focal, generalized, tonic, and myoclonic-atonic seizures; some children have breathing pauses during a seizure, called ictal apnea. Any unexplained breathing pause needs emergency medical attention.
What vision and eye problems can PIGT-related MCAHS3 cause?
Children may have reduced vision, crossed or misaligned eyes called strabismus, or involuntary eye movements called nystagmus. Rarely, abnormal development of the front of the eye or retinal detachment has been reported. A pediatric ophthalmologist can assess these concerns.
Are bone and joint problems part of PIGT-related MCAHS3?
They can be, but skeletal findings are inconsistent. Reported problems include fractures, delayed bone age, very flexible joints, clubfoot, and differences in the fingers or toes. Some children have no obvious skeletal problems.
Does every child with PIGT-related MCAHS3 have the same severity?
No. Symptoms can differ greatly, even between siblings with the same genetic change. Some reported children have seizures that are easier to control and less profound developmental delay, while others have treatment-resistant seizures and need extensive daily support.
Can PIGT-related MCAHS3 affect organs beyond the brain and eyes?
Yes, but these findings are less common and may not occur in every child. Reported features include kidney cysts or urine-flow problems, minor heart-position differences, and hearing loss. The care team can decide which evaluations are appropriate for an individual child.

Get notified when new evidence is published on Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (10)
  1. 1

    Deep-Phenotyping the Less Severe Spectrum of PIGT Deficiency and Linking the Gene to Myoclonic Atonic Seizures.

    Bayat A, Pendziwiat M, Obersztyn E, et al.

    Frontiers in genetics 2021; (12()):663643 doi:10.3389/fgene.2021.663643.

    PMID: 34046058
  2. 2

    Expanding the clinical and molecular characteristics of PIGT-CDG, a disorder of glycosylphosphatidylinositol anchors.

    Lam C, Golas GA, Davids M, et al.

    Molecular genetics and metabolism 2015; (115(2-3)):128-140 doi:10.1016/j.ymgme.2015.04.007.

    PMID: 25943031
  3. 3

    PIGT-CDG, a disorder of the glycosylphosphatidylinositol anchor: description of 13 novel patients and expansion of the clinical characteristics.

    Bayat A, Knaus A, Juul AW, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2019; (21(10)):2216-2223 doi:10.1038/s41436-019-0512-3.

    PMID: 30976099
  4. 4

    Novel PIGT Variant in Two Brothers: Expansion of the Multiple Congenital Anomalies-Hypotonia Seizures Syndrome 3 Phenotype.

    Skauli N, Wallace S, Chiang SC, et al.

    Genes 2016; (7(12)).

    PMID: 27916860
  5. 5

    Epileptic apnea in a patient with inherited glycosylphosphatidylinositol anchor deficiency and PIGT mutations.

    Kohashi K, Ishiyama A, Yuasa S, et al.

    Brain & development 2018; (40(1)):53-57 doi:10.1016/j.braindev.2017.06.005.

    PMID: 28728837
  6. 6

    Analyzing clinical and genetic characteristics of a cohort with multiple congenital anomalies-hypotonia-seizures syndrome (MCAHS).

    Jiao X, Xue J, Gong P, et al.

    Orphanet journal of rare diseases 2020; (15(1)):78 doi:10.1186/s13023-020-01365-0.

    PMID: 32220244
  7. 7

    Bilateral anterior segment dysgenesis and peripheral avascular retina with tractional retinal detachment in an infant with multiple congenital anomalies-hypotony-seizures syndrome 3.

    Wu F, Goldenberg PC, Mukai S

    Ophthalmic genetics 2021; (42(3)):334-337 doi:10.1080/13816810.2021.1888133.

    PMID: 33620284
  8. 8

    Case report of a child bearing a novel deleterious splicing variant in PIGT.

    Mason S, Castilla-Vallmanya L, James C, et al.

    Medicine 2019; (98(8)):e14524 doi:10.1097/MD.0000000000014524.

    PMID: 30813157
  9. 9

    Compound Heterozygous PIGT Mutations in Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome: First Case in Korea and Characterization by Persistent Hypophosphatasia.

    Hur YJ, Lee BL, Chung WY, et al.

    Annals of clinical and laboratory science 2021; (51(3)):422-425.

    PMID: 34162574
  10. 10

    A Novel Homozygous Missense Variant of PIGT Related to Multiple Congenital Anomalies-Hypotonia Seizures Syndrome 3 with Elevated of Serum ALP Level in a Thai Newborn Patient.

    Klangjorhor J, Wiwattanadittakul N, Jaimalai T, et al.

    International journal of molecular sciences 2025; (26(6)) doi:10.3390/ijms26062790.

    PMID: 40141433

This page is for informational purposes only and does not constitute medical advice. It describes reported symptoms of PIGT-related MCAHS3, but your child's care team should interpret their symptoms and testing.